Достижения в педиатрических исследованиях

Достижения в педиатрических исследованиях
Открытый доступ

ISSN: 2385-4529

Абстрактный

Neonatal Hypoglycemia: What Can We Improve?

Carolina Sole Delgado, Itziar Marsinyach Ros, Manuel Sanchez Luna

Background: Neonatal hypoglycemia is a frequent problem with potential neurological adverse effects and it involves a significant number of admissions to neonatal units with the consequent mother-child separation, difficulty in establishing breastfeeding and increased hospital expenditure. Although any newborn can suffer hypoglycemia, certain patients are at higher risk. Strategies to detect and prevent hypoglycemia in this subgroup of patients is a common practice in neonatology units. This study aims to analyze the impact of this situation in our center, in order to identify, areas for improvement.

Material and methods: We performed a retrospective review of newborns admitted for hypoglycemia in a tertiary hospitalization center during 2019 and 2020.

Results: 232 patients were admitted for hypoglycemia during this period, accounting for 11.5% of total admissions. Of these, 185 (79%) had known risk factors for hypoglycemia. The median gestational age was 37 (Interquartile Range (IQR) 36-38) and weight 2450 g (IQR 2255-2935 g). The most frequent risk factor was late prematurity (30.8%), followed by low birth weight (26%). Ninety percent had a pathological first blood glucose level. Median chronological age at admission was 6 (Resident Intelligence Quotient (RIQ) 4-10). A total of 42.7% were exclusively Breastfed (BF), 31.3% fed with Adapted Formula (AF) and 16.75% of the patients had not taken early enteral feedings (neither formula bottle nor breastfeeding) before the first glycemic control. The mean of the first glycemic value was significantly lower in those who did not take an early feed (mean 28.4, Standard Deviation (SD) 1.7) than those who did (mean 35.2, SD 0.88).

Conclusion: Admissions for neonatal hypoglycemia are frequent. Early intake was associated with a higher first glycemic control. This measure was only fulfilled within some patients in our center, so there is an opportunity for improvement.

Отказ от ответственности: Этот тезис был переведен с использованием инструментов искусственного интеллекта и еще не прошел рецензирование или проверку.
Top